Anemia is associated with abdominal aortic aneurysm (AAA) size and decreased long-term survival after endovascular AAA repair

Journal of Vascular Surgery

Volumn 46, Issue 4, 2007, Pages 676-681

  Diehm, Nicolas ^a,b   Benenati, James F ^a   Becker, Gary J ^c   Quesada, Ramon ^a   Tsoukas, Athanassios I ^a   Katzen, Barry T ^a   Kovacs, Margaret ^a  

^a BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; STATINE DERIVATIVE;

ABDOMINAL AORTA ANEURYSM; AGED; ANEMIA; ANEURYSM SURGERY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

AGED; ANEMIA; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; SURVIVAL RATE;

EID: 34548829368     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.06.027     Document Type: Article

References (54)

1. Szilagyi D.E., Smith R.F., DeRusso F.J., Elliott J.P., and Sherrin F.W. Contribution of abdominal aortic aneurysmectomy to prolongation of life. Ann Surg 164 (1966) 678-699
2. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., and Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15 (1995) 1145-1151
3. Diehm N., Schmidli J., Dai-Do D., and Baumgartner I. Current evidence and prospects for medical treatment of abdominal aortic aneurysms. VASA 34 (2005) 217-223
4. Greenhalgh R.M., Brown L.C., Kwong G.P., Powell J.T., and Thompson S.G. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomized controlled trial. Lancet 364 (2004) 843-848
5. Prinssen M., Verhoeven E.L., Buth J., Cuypers P.W., van Sambeek M.R., Balm R., et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351 (2004) 1607-1618
6. Arko F.R., Lee W.A., Hill B.B., Olcott C., Dalman R.L., Harris Jr. E.J., et al. Aneurysm-related death: primary endpoint analysis for comparison of open and endovascular repair. J Vasc Surg 36 (2002) 297-304
7. Zarins C.K., Crabtree T., Bloch D.A., Arko F.R., Ouriel K., and White R.A. Endovascular aneurysm repair at 5 years: Does aneurysm diameter predict outcome?. J Vasc Surg 44 (2006) 920-929
8. Brewster D.C., Jones J.E., Chung T.K., Lamuraglia G.M., Kwolek C.J., Watkins M.T., et al. Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade. Ann Surg 244 (2006) 426-438
9. Sicard G.A., Zwolak R.M., Sidawy A.N., White R.A., and Siami F.S. Endovascular abdominal aortic aneurysm repair: long-term outcome measures in patients at high-risk for open surgery. J Vasc Surg 44 (2006) 229-236
10. Jones K.G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
11. Vainas T., Lubbers T., Stassen F.R., Herngreen S.B., van Dieijen-Visser M.P., Bruggeman C.A., et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107 (2003) 1103-1105
12. Rohde L.E., Arroyo L.H., Rifai N., Creager M.A., Libby P., Ridker P.M., et al. Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol 19 (1999) 1695-1699
13. Norman P., Spencer C.A., Lawrence-Brown M.M., and Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 110 (2004) 862-866
14. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 365 (2005) 2187-2192
15. Lloyd G.M., Newton J.D., Norwood M.G., Franks S.C., Bown M.J., and Sayers R.D. Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction?. J Vasc Surg 40 (2004) 691-697
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
17. Schouten O., Kok N.F., Hoedt M.T., van Laanen J.H., and Poldermans D. The influence of aneurysm size on perioperative cardiac outcome in elective open infrarenal aortic aneurysm repair. J Vasc Surg 44 (2006) 435-441
18. Brady A.R., Fowkes F.G., Thompson S.G., and Powell J.T. Aortic aneurysm diameter and risk of cardiovascular mortality. Arterioscler Thromb Vasc Biol 21 (2001) 1203-1207
19. Peppelenbosch N., Buth J., Harris P.L., van Marrewijk C., and Fransen G. Diameter of abdominal aortic aneurysm and outcome of endovascular aneurysm repair: does size matter? A report from EUROSTAR. J Vasc Surg 39 (2004) 288-297
20. Schouten O., van Waning V.H., Kertai M.D., Feringa H.H., Bax J.J., Boersma E., et al. Perioperative and long-term cardiovascular outcomes in patients undergoing endovascular treatment compared with open vascular surgery for abdominal aortic aneurysm or iliaco-femoro-popliteal bypass. Am J Cardiol 96 (2005) 861-866
21. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 16 (2001) 36-40
22. Nissenson A.R., Goodnough L.T., and Dubois R.W. Anemia: not just an innocent bystander?. Arch Intern Med 163 (2003) 1400-1404
23. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
24. McClellan W.M., Flanders W.D., Langston R.D., Jurkovitz C., and Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 13 (2002) 1928-1936
25. Langston R.D., Presley R., Flanders W.D., and McClellan W.M. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int 64 (2003) 1398-1405
26. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
27. Matzner Y., Levy S., Grossowicz N., Izak G., and Hershko C. Prevalence and causes of anemia in elderly hospitalized patients. Gerontology 25 (1979) 113-119
28. Salive M.E., Cornoni-Huntley J., Guralnik J.M., Phillips C.L., Wallace R.B., Ostfeld A.M., et al. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc 40 (1992) 489-496
29. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 16 (2002) 87-96
30. Newman K.M., Jean-Claude J., Li H., Ramey W.G., and Tilson M.D. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90 (1994) 224-227
31. Parodi J.C., Palmaz J.C., and Barone H.D. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5 (1991) 491-499
32. Katzen B.T., Dake M.D., MacLean A.A., and Wang D.S. Endovascular repair of abdominal and thoracic aortic aneurysms. Circulation 112 (2005) 1663-1675
33. World Health Organization. Nutritional anemias: Report of a WHO Scientific Group (1968) Geneva, Switzerland
34. Chaikof E.L., Blankensteijn J.D., Harris P.L., White G.H., Zarins C.K., Bernhard V.M., et al. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 35 (2002) 1048-1060
35. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 4 (1986) 80-94
36. Moore W.S., Matsumura J.S., Makaroun M.S., Katzen B.T., Deaton D.H., Decker M., et al. Five-year interim comparison of the Guidant bifurcated endograft with open repair of abdominal aortic aneurysm. J Vasc Surg 38 (2003) 46-55
37. Faries P.L., Brener B.J., Connelly T.L., Katzen B.T., Briggs V.L., Burks Jr. J.A., et al. A multicenter experience with the Talent endovascular graft for the treatment of abdominal aortic aneurysms. J Vasc Surg 35 (2002) 1123-1128
38. Najibi S., Steinberg J., Katzen B.T., Zemel G., Lin P.H., Weiss V.J., et al. Detection of isolated hook fractures 36 months after implantation of the Ancure endograft: a cautionary note. J Vasc Surg 34 (2001) 353-356
39. Matsumura J.S., Katzen B.T., Hollier L.H., and Dake M.D. Update on the bifurcated EXCLUDER endoprosthesis: phase I results. J Vasc Surg 33 (2001) S150-S153
40. Jongen-Lavrencic M., Peeters H.R., Wognum A., Vreugdenhil G., Breedveld F.C., and Swaak A.J. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol 24 (1997) 1504-1509
41. Newman K.M., Jean-Claude J., Li H., Ramey W.G., and Tilson M.D. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90 (1994) II224-II227
42. Shteinberg D., Halak M., Shapiro S., Kinarty A., Sobol E., Lahat N., et al. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg 20 (2000) 462-465
43. Kragsterman B., Bjorck M., Lindback J., Bergqvist D., and Parsson H. Long-term survival after carotid endarterectomy for asymptomatic stenosis. Stroke 37 (2006) 2886-2891
44. van Wijk I., Kappelle L.J., van Gijn J., Koudstaal P.J., Franke C.L., Vermeulen M., et al. Long-term survival and vascular event risk after transient ischemic attack or minor ischemic stroke: a cohort study. Lancet 365 (2005) 2098-2104
45. Brenner H., Stegmaier C., and Ziegler H. Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol 16 (2005) 981-986
46. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 (2007) S5-S67
47. Ganz T. Molecular control of iron transport. J Am Soc Nephrol 18 (2007) 394-400
48. Konijn A.M., Carmel N., Levy R., and Hershko C. Ferritin synthesis in inflammation. II. Mechanism of increased ferritin synthesis. Br J Haematol 49 (1981) 361-370
49. Kertai M.D., Boersma E., Westerhout C.M., van Domburg R., Klein J., Bax J.J., et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116 (2004) 96-103
50. Leurs L.J., Visser P., Laheij R.J., Buth J., Harris P.L., and Blankensteijn J.D. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 14 (2006) 1-8
51. Nagashima H., Aoka Y., Sakomura Y., Sakuta A., Aomi S., Ishizuka N., et al. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 6 (2002) 158-163
52. Steinmetz E.F., Buckley C., Shames M.L., Ennis T.L., Vanvickle-Chavez S.J., Mao D., et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 241 (2005) 92-101
53. Wilson W.R., Evans J., Bell P.R., and Thompson M.M. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 3 (2005) 259-262
54. Schrier S. Anemia of chronic disease (anemia of inflammation). In: www.uptodate.com; accessed March 2007.